Cargando…

Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine

The development of age-appropriate formulations should focus on dosage forms that can deliver variable yet accurate doses that are safe and acceptable to the child, are matched to his/her development and ability, and avoid medication errors. However, in the past decade, the medication needs of neona...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Brien, Fiona, Clapham, David, Krysiak, Kamelia, Batchelor, Hannah, Field, Peter, Caivano, Grazia, Pertile, Marisa, Nunn, Anthony, Tuleu, Catherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600135/
https://www.ncbi.nlm.nih.gov/pubmed/31159216
http://dx.doi.org/10.3390/ijms20112688
_version_ 1783431054576582656
author O’Brien, Fiona
Clapham, David
Krysiak, Kamelia
Batchelor, Hannah
Field, Peter
Caivano, Grazia
Pertile, Marisa
Nunn, Anthony
Tuleu, Catherine
author_facet O’Brien, Fiona
Clapham, David
Krysiak, Kamelia
Batchelor, Hannah
Field, Peter
Caivano, Grazia
Pertile, Marisa
Nunn, Anthony
Tuleu, Catherine
author_sort O’Brien, Fiona
collection PubMed
description The development of age-appropriate formulations should focus on dosage forms that can deliver variable yet accurate doses that are safe and acceptable to the child, are matched to his/her development and ability, and avoid medication errors. However, in the past decade, the medication needs of neonates have largely been neglected. The aim of this review is to expand on what differentiates the needs of preterm and term neonates from those of the older paediatric subsets, in terms of environment of care, ability to measure and administer the dose (from the perspective of the patient and carer, the routes of administration, the device and the product), neonatal biopharmaceutics and regulatory challenges. This review offers insight into those challenges posed by the formulation of medicinal products for neonatal patients in order to support the development of clinically relevant products.
format Online
Article
Text
id pubmed-6600135
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-66001352019-07-16 Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine O’Brien, Fiona Clapham, David Krysiak, Kamelia Batchelor, Hannah Field, Peter Caivano, Grazia Pertile, Marisa Nunn, Anthony Tuleu, Catherine Int J Mol Sci Review The development of age-appropriate formulations should focus on dosage forms that can deliver variable yet accurate doses that are safe and acceptable to the child, are matched to his/her development and ability, and avoid medication errors. However, in the past decade, the medication needs of neonates have largely been neglected. The aim of this review is to expand on what differentiates the needs of preterm and term neonates from those of the older paediatric subsets, in terms of environment of care, ability to measure and administer the dose (from the perspective of the patient and carer, the routes of administration, the device and the product), neonatal biopharmaceutics and regulatory challenges. This review offers insight into those challenges posed by the formulation of medicinal products for neonatal patients in order to support the development of clinically relevant products. MDPI 2019-05-31 /pmc/articles/PMC6600135/ /pubmed/31159216 http://dx.doi.org/10.3390/ijms20112688 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
O’Brien, Fiona
Clapham, David
Krysiak, Kamelia
Batchelor, Hannah
Field, Peter
Caivano, Grazia
Pertile, Marisa
Nunn, Anthony
Tuleu, Catherine
Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine
title Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine
title_full Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine
title_fullStr Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine
title_full_unstemmed Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine
title_short Making Medicines Baby Size: The Challenges in Bridging the Formulation Gap in Neonatal Medicine
title_sort making medicines baby size: the challenges in bridging the formulation gap in neonatal medicine
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600135/
https://www.ncbi.nlm.nih.gov/pubmed/31159216
http://dx.doi.org/10.3390/ijms20112688
work_keys_str_mv AT obrienfiona makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine
AT claphamdavid makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine
AT krysiakkamelia makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine
AT batchelorhannah makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine
AT fieldpeter makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine
AT caivanograzia makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine
AT pertilemarisa makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine
AT nunnanthony makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine
AT tuleucatherine makingmedicinesbabysizethechallengesinbridgingtheformulationgapinneonatalmedicine